Both in Pharmaceuticals
Climb Bio vs Capricor Therapeutics
Over the past year CLYM returned +396.3% and CAPR returned +47.2%; their daily moves had a correlation of 0.15.
CLYM +396.3% CAPR +47.2%Growth of $1, one year, split-adjusted
| Metric | CLYM | CAPR |
|---|---|---|
| Price | $9.33 | $8.92 |
| Market cap | $535.9M | $518.6M |
| Today | −4.31% | +8.25% |
| 1 month | −12.6% | +15.1% |
| 6 months | −23.6% | −74.1% |
| Year to date | +133.3% | −69.1% |
| 1 year | +366.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $183.1M | $237.9M |
| Dividend yield | — | — |
| Volatility (60d) | 80.8% | 144.1% |
| Short % of float | 25.6% | 48.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).